GENERIX : Further to our press release dated January 27, 2012
04/04/2012| 12:35pm US/Eastern
Further to our press release dated January 27, 2012
Paris, April 4, 2012 - Generix Group, collaborative software vendor for Retail ecosystem, today completed its Press Release dated January 27, 2012, concerning its revenues for the third quarter, ended December 31, 2011, of its financial year 2011/2012.
The 5% growth of the third quarter turnover compared to the same quarter last year has a positive impact on the Group's operating income, this growth mostly driven by better Licence sales.
The successful capital increase for 8.3 millions of Euros also marked the third quarter.
These two factors have enable to improve the cash and the net debt of the Group over the six months situation ended Septembre 30, 2011.
Next press release: April 20, 2012
Revenues of financial year 2011/2012
Investor relations Press contact
Ludovic LUZZA Stéphanie STAHR
Financial Director CM-CIC Emetteur
+33 (0) 1 77 45 42 80 +33 (0)1 45 96 77 83
About Generix Group
Generix Group provides the rapidly evolving Retail Ecosystem with leading Collaborative Software Solutions to operate profitably, adjust effectively, and grow sustainably. Generix Group helps retailers, third party logistics providers and manufacturers, in managing, sharing and optimizing their data flows. Generix Collaborative Business portfolio relies on a strong business expertise encompassing ERP, Supply Chain and Cross-Channel management, and uniquely leverages an A2A/B2B Gateway and Portal solutions.
Carrefour, Cdiscount, DHL, Gefco, Kuehne + Nagel, Leclerc, Leroy Merlin, Louis Vuitton, Metro, Nestlé, Sara Lee, Sodiaal, Unilever... more than 1,500 international companies trust "Generix Collaborative Business" solutions to profitably run their business, establishing Generix Group as an European leader with 66+M€ revenue.
Further to our press release dated January 27, 2012 :
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Generix Group via Thomson Reuters ONE